Coming October 2: SITC releases abstract titles with each presenting author’s institution (nearly 1,300 last year). We’ll add them to this guide once they’re out.

Cell therapy at SITC 2026

Nov 4–8, 2026 Phoenix, AZ ~6k attendees Website

42 organizations at SITC 2026 present work in cell therapy: 15 suppliers and service providers, 11 pharma and biotech companies, 9 universities and research institutes, 5 cancer centres and hospitals and 2 government and non-profit bodies. Between them they bring 50 presentations to the program. Most represented: Dana-Farber Cancer Institute (6 on the program), Massachusetts General Hospital (6 on the program), National Cancer Institute (5 on the program). 31 of them have their own page in this guide. As of Sep 29, 2026.

All 242 organizations at SITC 2026 →

Showing 1–6 of 42 organizations

Organization	SITC 2026 Attendance
Dana-Farber Cancer Institute Boston, MA
dana-farber.org Cancer centres & hospitals Harvard-affiliated cancer treatment and research center in Boston.	Workshop Thu Nov 5 5:00pm–9:00pm Launching Biotech Startups: Funding, Pitching, Partnerships 5:00pm–5:45pmWelcome Reception 5:55pm–6:55pmHigh-Impact Talks from Pharma Leaders 6:55pm–7:15pmPanel 7:00pm–7:50pmFinancing and Partnership Panel 8:00pm–9:00pmClosing Networking Reception Plenary Fri Nov 6 8:40am–9:10am Part of Session 102: Richard V. Smalley Memorial Award and Lectureship Getting Off the Rollercoaster: Personalized Cancer Vaccines Come of Age Halls BC Vaccines Plenary Fri Nov 6 11:10am–11:30am Part of Session 103: Thomas Waldmann Memorial Plenary Session: Cancer Vaccines, Current and Future The Cancer Dark Proteome: A Rich Source of Tumor-Selective Cryptic Antigens Halls BC Vaccines Session Fri Nov 6 9:40am–11:30am Thomas Waldmann Memorial Plenary Session: Cancer Vaccines, Current and Future Halls BC Vaccines 9:44am–10:04amDiscovery and Development of a Pancreatic Cancer RNA VaccineMemorial Sloan Kettering Cancer Center 10:04am–10:24amUpdates on Clinical Results from the AMPLIFY-7P Study of a Lymph Node-Targeted Kras VaccineScripps Research 10:24am–10:37amAbstract presentation — title not yet released 10:37am–10:57amLearning from Checkpoint Blockade: Prioritizing Neoantigens and Shared Tumor Antigens for Cancer VaccinesUniversity of Toulouse 10:57am–11:10amAbstract presentation — title not yet released 11:10am–11:30amThe Cancer Dark Proteome: A Rich Source of Tumor-Selective Cryptic AntigensDana-Farber Cancer Institute Talk Fri Nov 6 2:10pm–2:30pm Part of Session 106a: Combination Therapies Involving Cell Therapy CAR-Enhancers: Programmable Boosters for Durable Cell Therapy Halls BC Cell therapy Talk Fri Nov 6 2:30pm–2:45pm Part of Session 106b: Human Ex Vivo Models for Immunotherapy Testing: From Tumor Explants to Tumor-on-Chip Dynamic Immune Profiling Using Human Ex Vivo Tumor Models 301A Models & tech Session Sat Nov 7 5:20pm–6:40pm Oral Abstract Session 4 301D 5:20pm–6:35pm5 abstract presentations — titles not yet released
Massachusetts General Hospital Boston, MA
massgeneral.org Cancer centres & hospitals Harvard teaching hospital in Boston and home of the Mass General Cancer Center.	Session Thu Nov 5 12:00pm–1:30pm Collaborating with Industry Encanto AB Session Fri Nov 6 1:45pm–3:25pm Mechanisms of irAEs Hall A Clinical 1:50pm–2:10pmDiet and Microbiome Drivers of Immune Related Adverse EventsUniversity of Pittsburgh 2:10pm–2:30pmUnlocking the Specificity of the Autoimmune Response in iRAE’sUCSF 2:30pm–2:50pmClinical Trials for irAEs: Where Do We Go Next?Vanderbilt University Medical Center 2:55pm–3:25pm2 abstract presentations — titles not yet released Talk Sat Nov 7 4:15pm–4:25pm Part of Session 206c: Microbiome and Metabolism Gut Microbiota Metabolite Control of Antitumor CD8 T Cell Trafficking 301A Tumor biology Session Sat Nov 7 3:30pm–4:50pm IO in Low Mutation Burden Cancers Hall A Tumor biology 3:35pm–3:55pmTargeted Therapy + ImmunotherapyJohns Hopkins University 3:55pm–4:15pmFrom the Clinic to the Lab: Investigating Mechanisms of Response and Resistance to Immune Checkpoint TherapyMD Anderson Cancer Center 4:15pm–4:35pmBeyond the Canonical Proteome: Identifying Immunogenic Targets in Ovarian TumorsMayo Clinic 4:35pm–4:50pmAbstract presentation — title not yet released Session Sat Nov 7 3:30pm–4:50pm Microbiome and Metabolism 301A Tumor biology 3:30pm–3:45pmCorrecting the Gut Microbiome Dysbiosis in OncologyCentre hospitalier de l'Université de Montréal (CHUM) 3:45pm–4:00pmToward Metabotherapy for CancerStanford University 4:00pm–4:15pmIntratumoral Bacterial Elements in Brain TumorsMoffitt Cancer Center 4:15pm–4:25pmGut Microbiota Metabolite Control of Antitumor CD8 T Cell TraffickingMassachusetts General Hospital 4:25pm–4:35pmGut Microbiome Function Shapes the Efficacy of Tumor Infiltrating Lymphocyte (TIL) Therapy in MelanomaUniversity of Pittsburgh Talk Sat Nov 7 5:40pm–5:55pm Part of Session 207d: Cellular Therapies Learnings From a CAR-T Driver Into Solid Tumor Halls BC Cell therapy Talk Sun Nov 8 10:45am–11:00am Part of Session 303: COOPERATIVE BINDING: The bi-specific VEGF/PD(L)-1 Inhibitor Approach to cancer immunotherapy: Savior or Pretender? Biology of anti-VEGF treatment Hall A New agents · Tumor biology
National Cancer Institute Bethesda, MD
cancer.gov Government & non-profit US federal agency for cancer research and training, part of the National Institutes of Health.	Session Thu Nov 5 12:00pm–1:30pm Careers Outside Academia and Industry – Careers in Policy, Advocacy and Non-Profit Organizations Encanto AB Talk Thu Nov 5 3:35pm–3:50pm Part of Session I – Grant Writing Essentials Considerations for Using AI Encanto AB Talk Thu Nov 5 2:35pm–2:45pm Part of Session I – Grant Writing Essentials Overview of NIH Grants Encanto AB Session Fri Nov 6 8:00am–8:05am Presidential Welcome Halls BC Session Fri Nov 6 3:55pm–5:30pm Oral Abstract Session 2 301D 3:55pm–5:25pm6 abstract presentations — titles not yet released Talk Sat Nov 7 6:02pm–6:20pm Part of Session 207b: AI-driven Protein Design to Enhance Cancer Immunotherapy T cell phenotype and protein structure-informed discovery of TCRs for cell therapy 301BC Cell therapy · AI & data Session Sun Nov 8 8:15am–9:40am Presidential Session Hall A 8:20am–9:20am4 abstract presentations — titles not yet released 9:20am–9:30amExpert DisucussantUniversity of Pittsburgh
University of Pittsburgh Pittsburgh, PA
pitt.edu Universities & research institutes Public research university in Pittsburgh, Pennsylvania.	Session Thu Nov 5 12:00pm–1:30pm Navigating Academia as Junior Faculty (as MD or PhD) Encanto AB Talk Thu Nov 5 3:15pm–3:25pm Part of Session I – Grant Writing Essentials Funding Your Research Through Industry Collaboration Encanto AB Workshop Thu Nov 5 2:30pm–5:05pm Grant Writing Workshop 2:30pm–4:30pmSession I – Grant Writing Essentials 4:05pm–4:30pmThe Importance of the Patient Advocate Perspective in Research and How to Effectively Connect with Advocates 4:30pm–5:00pmSession II – Breakout Sessions 5:00pm–5:05pmClosing Talk Thu Nov 5 4:30pm–5:00pm Part of Session II – Breakout Sessions Breakout Table: Interfacing with Industry (Biotech Grants) Encanto AB Talk Thu Nov 5 4:30pm–5:00pm Part of Session II – Breakout Sessions Breakout Table: Low-preliminary Data Grants (DP5, R21, High Risk/High Reward Grants) Encanto AB Talk Fri Nov 6 1:50pm–2:10pm Part of Session 106d: Mechanisms of irAEs Diet and Microbiome Drivers of Immune Related Adverse Events Hall A Clinical · Tumor biology Session Sat Nov 7 9:35am–11:15am Spatial Biology Halls BC Models & tech 9:40am–10:00amHigh-plex Imaging and Spatial TranscriptomicsUniversity of Queensland 10:00am–10:20amSpatial Biomarkers of Immunotherapy ResponseMD Anderson Cancer Center 10:20am–10:40amComputational Spatial Biology and AI-assisted InterpretationProvidence Genomics 10:40am–11:10am2 abstract presentations — titles not yet released Session Sat Nov 7 11:15am–12:15pm Hot Topic Symposium: External Factors Contributing to Immunotherapy Response Halls BC Tumor biology 11:15am–11:30amPostprandial Metabolism and its Potential to Enhance Immunotherapy ResponsesUniversity of Pittsburgh 11:30am–11:45amThe Role of the Intestinal Microbiome in Cancer ImmunotherapyCity of Hope 11:45am–12:05pmDebate: Pros and Cons on Time of Day and Checkpoint InhibitorsEmory University School of Medicine, Fred Hutchinson Cancer Center Talk Sat Nov 7 11:15am–11:30am Part of Session 203: Hot Topic Symposium: External Factors Contributing to Immunotherapy Response Postprandial Metabolism and its Potential to Enhance Immunotherapy Responses Halls BC Tumor biology Talk Sat Nov 7 4:25pm–4:35pm Part of Session 206c: Microbiome and Metabolism Gut Microbiome Function Shapes the Efficacy of Tumor Infiltrating Lymphocyte (TIL) Therapy in Melanoma 301A Tumor biology · Cell therapy Session Sat Nov 7 3:30pm–4:50pm Microbiome and Metabolism 301A Tumor biology 3:30pm–3:45pmCorrecting the Gut Microbiome Dysbiosis in OncologyCentre hospitalier de l'Université de Montréal (CHUM) 3:45pm–4:00pmToward Metabotherapy for CancerStanford University 4:00pm–4:15pmIntratumoral Bacterial Elements in Brain TumorsMoffitt Cancer Center 4:15pm–4:25pmGut Microbiota Metabolite Control of Antitumor CD8 T Cell TraffickingMassachusetts General Hospital 4:25pm–4:35pmGut Microbiome Function Shapes the Efficacy of Tumor Infiltrating Lymphocyte (TIL) Therapy in MelanomaUniversity of Pittsburgh Plenary Sun Nov 8 9:20am–9:30am Part of Session 301: Presidential Session Expert Disucussant Hall A
Stanford University Stanford, CA
stanford.edu Universities & research institutes Private research university in California, home of Stanford Medicine.	Session Thu Nov 5 12:00pm–1:30pm Collaborating with Industry on Investigator-initiated Clinical Trials Encanto AB Clinical Talk Thu Nov 5 3:25pm–3:35pm Part of Session I – Grant Writing Essentials Assembling a Successful Young Investigator and Career Development Award Application for Foundations Encanto AB Workshop Thu Nov 5 2:30pm–5:05pm Grant Writing Workshop 2:30pm–4:30pmSession I – Grant Writing Essentials 4:05pm–4:30pmThe Importance of the Patient Advocate Perspective in Research and How to Effectively Connect with Advocates 4:30pm–5:00pmSession II – Breakout Sessions 5:00pm–5:05pmClosing Workshop Thu Nov 5 2:30pm–4:30pm Session I – Grant Writing Essentials Encanto AB 2:35pm–2:45pmOverview of NIH GrantsNational Cancer Institute 2:45pm–2:55pmStructuring the Necessary Framework for a Winning GrantWeill Cornell Medicine 2:55pm–3:05pmEffective Grant Proposal Writing and Avoiding Common PitfallsUniversity of Wisconsin-Madison 3:05pm–3:15pmK or F Awards? Finding Your NIH Career Development AwardsUniversity of Pennsylvania 3:15pm–3:25pmFunding Your Research Through Industry CollaborationUniversity of Pittsburgh 3:25pm–3:35pmAssembling a Successful Young Investigator and Career Development Award Application for FoundationsStanford University 3:35pm–3:50pmConsiderations for Using AINational Cancer Institute Talk Thu Nov 5 4:30pm–5:00pm Part of Session II – Breakout Sessions Breakout Table: Grants for Physician Scientists (K08 awards and others) Encanto AB Talk Fri Nov 6 1:50pm–2:10pm Part of Session 106c: Immunosenescence Aging and T-Cell Fitness 301BC Tumor biology Talk Fri Nov 6 1:50pm–2:10pm Part of Session 106a: Combination Therapies Involving Cell Therapy Cytokine Recipes for T cell immunotherapy Halls BC Cell therapy · New agents Talk Sat Nov 7 3:45pm–4:00pm Part of Session 206c: Microbiome and Metabolism Toward Metabotherapy for Cancer 301A Tumor biology
UCSF San Francisco, CA
ucsf.edu Universities & research institutes University of California health sciences campus in San Francisco focused on biomedical research and medicine.	Talk Thu Nov 5 3:10pm–3:25pm Part of Session IV: Emerging Technologies – Incorporation into Clinical Trials In vivo and Solid Tumor CAR-T Cell Therapies Valley of the Sun Ballroom Cell therapy Talk Fri Nov 6 2:10pm–2:30pm Part of Session 106d: Mechanisms of irAEs Unlocking the Specificity of the Autoimmune Response in iRAE’s Hall A Clinical Session Fri Nov 6 3:55pm–5:30pm Immuno-oncology at Immune-privileged Sites Hall A Tumor biology 4:00pm–4:20pmThe Brain Is Not Immune to ImmunityUCSF 4:20pm–4:40pmThe Immune Tumor Microenvironment in Liver CancerNational Institutes of Health 4:40pm–5:00pmThe Privilege of Ocular ImmunityUniversity of Colorado 5:00pm–5:30pm2 abstract presentations — titles not yet released Talk Fri Nov 6 4:00pm–4:20pm Part of Session 107a: Immuno-oncology at Immune-privileged Sites The Brain Is Not Immune to Immunity Hall A Tumor biology Session Sat Nov 7 5:20pm–6:40pm Cellular Therapies Halls BC Cell therapy 5:25pm–5:40pmGenetic, Structural, Chemical and In Situ Engineering of Cell TherapyYale School of Medicine 5:40pm–5:55pmLearnings From a CAR-T Driver Into Solid TumorMassachusetts General Hospital 5:55pm–6:10pmEx Vivo and In Vivo Genome Editing to Reprogram T Cell FunctionUCSF 6:10pm–6:25pmAbstract presentation — title not yet released Talk Sat Nov 7 5:55pm–6:10pm Part of Session 207d: Cellular Therapies Ex Vivo and In Vivo Genome Editing to Reprogram T Cell Function Halls BC Cell therapy